Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSidney Kimmel Comprehensive Cancer Center at Johns Hopkins

About this trial

This is a single-center, prospective, single-arm study evaluating the safety and feasibility of total pancreatectomy with islet autotransplantation (TPIAT) in carefully selected adult patients with periampullary neoplasms who are considered at high risk for postoperative pancreatic fistula after pancreaticoduodenectomy. Eligible patients will undergo open or robotic TPIAT as part of the patient's surgical management. Perioperative outcomes, postoperative complications, metabolic outcomes, and early oncologic outcomes will be collected prospectively as part of routine clinical care and analyzed to assess the safety and feasibility of this approach.

Eligibility criteria

Qualifiers

Adults aged 18 and older.

Distal bile duct adenocarcinoma

Duodenal adenocarcinoma

Leiomyosarcoma of the duodenum

Disqualifiers

Pregnancy

Active alcohol or illicit drug use

Poorly controlled psychiatric illness that limits compliance with care

Pre-existing insulin-dependent diabetes with absent C-peptide

Trial design

Treatments tested in this trial

  • Total Pancreatectomy with Islet Autotransplantation (TPIAT)

Treatment groups

30 Participants
are divided into 1 treatment group

Locations

This trial has no locations